Search Results 1001-1010 of 21310 for anti-TNF drugs

1. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

   Treatment with Class Ia or Class III anti-arrhythmic drugs or treatment with two or more agents in combination known to prolong PR interval. Are receiving ...

2. Fexofenadine (Oral Route) Description and Brand Names - Mayo Clinic

   Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause ...

3. Alfuzosin (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

4. Natalizumab-Sztn (Intravenous Route) Description and Brand Names - Mayo Clinic

   Natalizumab-sztn injection is also used to treat moderate to severe Crohn's disease (CD) when other medicines or treatments did not work well.

5. Science Saturday: Finding the right drug, dose for cancer therapy through pharmacogenomics - Mayo Clinic News Network

   Now using pharmacogenomics testing, which looks at how a person's genetic traits affect their medication response, and a new gene verifier model, Dr. Diasio and ...

6. Teriparatide (Subcutaneous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Carbonic Anhydrase Inhibitor (Oral Route, Parenteral Route) Before Using - Mayo Clinic

   Be sure you have discussed this with your doctor. Drug Interactions. Although certain medicines should not be used together at all, in other cases two different ...

8. Pulmonary Medicine News - Medical Professionals - Mayo Clinic

   Updates in interstitial lung disease: Current facets of anti-fibrotic therapy. Teng Moua, M.D., discusses recent clinical trials and current research into the ...

9. Levothyroxine (Oral Route) Proper Use - Mayo Clinic

   Proper Use. Drug information provided by: Merative, Micromedex®. This medicine will need to be taken for the rest of your life or your child's ...

10. A Trial of Tumor Necrosis Factor Alpha and Interleukin-2 Coding Oncolytic Adenovirus (TILT-123) Combined with Pembrolizumab to Treat Refractory Ovarian Cancer - Mayo Clinic

    - Treated with any anti-cancer therapy within 30 days prior to the first virus injection. Anti-cancer therapy is defined as anti-cancer agents (e.g. surgery,